CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study aims to decrease the racial gap in type 2 diabetes control in African American and Latinx patients in Rush University Medical Cen...
Chicago, Illinois, United States
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Evanston, Illinois, United States and 45 other locations
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Chicago, Illinois, United States and 17 other locations
blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...
Phase 2
Chicago, Illinois, United States and 26 other locations
Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...
Phase 2
Chicago, Illinois, United States and 56 other locations
placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...
Phase 2
Chicago, Illinois, United States and 13 other locations
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answ...
Phase 2
Chicago, Illinois, United States and 5 other locations
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...
Phase 3
Chicago, Illinois, United States and 55 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Chicago, Illinois, United States and 42 other locations
transplantation in improving glycemic control in Type 1 diabetic patients using the UIC protocol that was developed and proven effective du...
Phase 3
Chicago, Illinois, United States
Clinical trials
Research sites
Resources
Legal